Searched for
CONTRACEPTIVE MANUFACTURING
620% rally makes Cupid the costliest stock in its category at 197 P/E. Should investors be cautious?Cupid, a contraceptives manufacturer, has seen a remarkable 620% rally in the past year, making it the costliest stock in its category with...- OTC morning-after pills to be sold in varying doses, with warning: SourcesMorning-after pills will continue to be available without a prescription. However, they will now feature a prominent boxed warning. This wa...
- HLL Lifecare reports annual condom production of 221.7 crHLL Lifecare, a Kerala-based PSU, produces 221.7 crore condoms annually, solidifying its position as a leading global manufacturer. With ei...
- UK launches first trial of hormone-free male birth control pill. Details insideUK trials hormone-free male pill, YCT-529, blocking vitamin A for contraception. Promising, reversible, and side-effect-free; trial ends Ju...
- Contraceptive companies, CMSS spar over tendersThe All India Condom Manufacturer Association, which includes various firms that manufacture condom brand Nirodh, has written to the govern...
- Lupin initiates recall of tablet Mibelas 24 Fe from US marketAccording to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'clas...
- MHL Healthcare Ltd drags Centre to Delhi High Court on supply of condomsThe Court was hearing a petition filed by private company MHL Healthcare Ltd expressing apprehension that like last year, the Centre may ca...
- Pharma firms may flood market with luxury condoms if price cap removed: Centre to HCThe court said in response that the government can impose conditions on the companies to maintain the same proportion of manufacture as of ...
- US PE firm TA Associates in talks to buy 35% stake in drugmaker Famy Care for Rs 1,200 croreThe shareholders’ agreement between AIF Capital and the promoters gives a drag-along right to the fund in case of an exit.
- Glenmark Pharma rallies over 3% on talks to sell oral contraceptive unit"Given complex manufacturing processes and high investments, the competition is low in the segment and typically attracts only a few player...
- Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
- Cipla looking to expand contraceptive pills business; in talks with International Planned ParenthoodThe country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...
- HLL lifecare launches natural birth control toolPublic sector HLL Lifecare Ltd has introduced a natural family planning tool that would enable couples to control birth by keeping track of...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- HLL Lifecare plans IPO in next nine monthsState-owned contraceptives manufacturer HLL Lifecare said it plans to come up with an initial public offer to raise funds in next nine mont...
- AIF Capital to invest $40 mn in Famy CareAIF Capital, one of the largest Asia-based independent private equity firms, on Wednesday announced that AIF Capital Asia III, LP has inves...
- Baring may acquire 15% in Famy CareBaring Private Equity Partners (India) is the front-runner to buy about 15% stake in Mumbai-based drugmaker Famy Care for around $40 millio...
- Morning after, men try to find what's i-pillPharma major Cipla's toll-free helpline number on emergency contraceptives receives 300 calls per day, a good 40% of them from men. Investo...
- HLL targeting 60% growthContraceptives major, Hindustan Latex Ltd (HLL) is targeting a 60 per cent growth in the current fiscal eyeing a turnover of Rs 350 crore t...
- America all set to get into the 'mood'At last the land of the Kamasutra will connect with the American male as Moods enters the US market.
Load More
